The over-expression or aberrant NFκβ subunits eventually results in the enhanced expression of NFκβ responsive genes like cyclin E that contributes to breast cancer progression, cyclin E is expressed in many breast cancer cell lines and associated with poor prognosis [79]. The gene discussed is CCNE1; the disease is breast carcinoma.